Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PFE

Pfizer Inc.

May 01 • 02:07PM ET

27.10

Dollar change +1.48
Percentage change 5.80	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO SCHD IVV VTV VYM VHT IWD MOAT DVY

Scroll to Statements

Index	S&P 500	P/E	75.42	EPS (ttm)	0.36	Insider Own	0.04%	Shs Outstand	5.65B	Perf Week	3.18%
Market Cap	153.06B	Forward P/E	9.92	EPS next Y	2.73	Insider Trans	0.13%	Shs Float	5.64B	Perf Month	-1.62%
Income	2.13B	PEG	-	EPS next Q	0.44	Inst Own	70.13%	Short Float	1.21%	Perf Quarter	0.09%
Sales	58.50B	P/S	2.62	EPS this Y	19.91%	Inst Trans	0.52%	Short Ratio	1.65	Perf Half Y	-11.28%
Book/sh	15.77	P/B	1.72	EPS next Y	23.87%	ROA	1.01%	Short Interest	68.06M	Perf Year	-30.87%
Cash/sh	2.25	P/C	12.06	EPS next 5Y	-1.33%	ROE	2.31%	52W Range	25.20 - 40.37	Perf YTD	-5.85%
Dividend Est.	1.69 (6.23%)	P/FCF	31.93	EPS past 5Y	-27.43%	ROI	1.39%	52W High	-32.85%	Beta	0.62
Dividend TTM	1.65 (6.09%)	Quick Ratio	0.69	Sales past 5Y	10.96%	Gross Margin	48.99%	52W Low	7.56%	ATR (14)	0.56
Dividend Ex-Date	May 09, 2024	Current Ratio	0.91	EPS Y/Y TTM	-93.20%	Oper. Margin	6.16%	RSI (14)	58.56	Volatility	1.87% 1.76%
Employees	88000	Debt/Eq	0.84	Sales Y/Y TTM	-41.70%	Profit Margin	3.65%	Recom	2.32	Target Price	31.22
Option/Short	Yes / Yes	LT Debt/Eq	0.72	EPS Q/Q	-168.11%	Payout	439.41%	Rel Volume	1.85	Prev Close	25.62
Sales Surprise	7.25%	EPS Surprise	58.98%	Sales Q/Q	-41.34%	Earnings	May 01 BMO	Avg Volume	41.13M	Price	27.10
SMA20	3.93%	SMA50	0.83%	SMA200	-10.80%	Trades		Volume	55,112,873	Change	5.80%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60
Nov-18-22	Initiated	Credit Suisse	Outperform	$55
May-23-22	Initiated	SVB Leerink	Mkt Perform	$55
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$55
Jan-05-22	Upgrade	BofA Securities	Neutral → Buy	$59 → $70
Jan-03-22	Reiterated	Bernstein	Mkt Perform	$44 → $65

Show Previous Ratings

Today 01:23PM	Pfizer Stock Gets Boost From Better-Than-Expected Earnings (Investopedia) +5.80%
01:18PM	Pfizer Stock Is Near An 11-Year Low But Is It A Buy On This 'Massive' Upside? (Investor's Business Daily)
12:38PM	Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations (Benzinga)
12:22PM	Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits (MT Newswires)
12:17PM	These Stocks Are Moving the Most Today: CVS, AMD, Super Micro, Amazon, Starbucks, Pfizer, Norwegian, Pinterest, DuPont, and More (Barrons.com)
11:43AM	Loading…
11:43AM	Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised (Zacks)
10:45AM	Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise (Investor's Business Daily)
10:43AM	Market Chatter: Pfizer Plans to Launch Online Platform for COVID-19, Migraine Drugs (MT Newswires)
09:54AM	Pfizer raises full-year outlook, stock rises on Q1 beat (Yahoo Finance Video)
09:48AM	Stocks to Watch Wednesday: Starbucks, Pfizer, CVS, Amazon (The Wall Street Journal)
09:32AM	Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline (GuruFocus.com)
09:30AM	Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
09:05AM	Pfizer Stock Rises as Outlook Rises After Earnings Beat (Barrons.com)
08:50AM	Pfizer Jumps After Raising Its Outlook On The Heels Of A Big Quarterly Beat (Investor's Business Daily)
08:44AM	Pfizer Lifts Full-Year 2024 Earnings Outlook Following First-Quarter Beat (MT Newswires)
08:18AM	Loading…
08:18AM	Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales (CNBC TV)
07:55AM	Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates (Zacks)
07:30AM	Amazon jumps on earnings, Fed decision nears: Yahoo Finance (Yahoo Finance Video)
07:20AM	Pfizer Q1 Adjusted Earnings, Revenue Decline; 2024 Adjusted Earnings Outlook Lifted -- Shares Gain Pre-Bell (MT Newswires)
07:13AM	Pfizer Stock Rises as Outlook Raised After Earnings Beat (Barrons.com)
07:05AM	Pfizer Boost FY24 Adj. EPS Outlook - Update (RTT News)
06:54AM	Pfizer: Q1 Earnings Snapshot (Associated Press Finance)
06:50AM	Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid demand (Reuters)
06:45AM	Pfizer Reports First-Quarter 2024 Results (Business Wire)
Apr-30-24 05:38PM	Fed rate decision, Qualcomm earnings: What to Watch (Yahoo Finance Video)
04:30PM	Pfizers Earnings Are Due. Questions About the Companys Outlook Linger. (Barrons.com)
01:50PM	7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdowns (InvestorPlace)
10:30AM	As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response (PR Newswire)
10:02AM	Pfizer and Genmabs Tivdak wins full FDA approval for cervical cancer (Pharmaceutical Technology)
07:45AM	5 Top Stocks to Buy in May (Motley Fool)
07:22AM	Loading…
07:22AM	FDA approves Labcorp companion diagnostic for Pfizer gene therapy (Medical Device Network)
07:14AM	Genmab and Pfizer's TIVDAK sBLA secures full FDA approval (Pharmaceutical Business Review)
05:50AM	Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist (Motley Fool)
05:06AM	Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Instead (Motley Fool)
02:00AM	Chasing Novo and Lilly: The obesity drugs that could challenge Wegovy and Zepbound (BioPharma Dive)
Apr-29-24 06:40PM	TIVDAK (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer (Business Wire)
06:40PM	FDA Grants Full Approval for TIVDAK to Treat Recurrent or Metastatic Cervical Cancer (Business Wire)
04:51PM	UPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug (Reuters)
03:58PM	US FDA grants full approval for Pfizer's cervical cancer drug (Reuters)
03:40PM	These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To Climb (Benzinga)
03:25PM	13 Best Reddit Stocks to Buy Now (Insider Monkey)
12:12PM	Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings (Zacks)
12:02PM	mRNA Is Promising A Breakthrough In Fighting Cancer (Benzinga)
10:17AM	Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy (MT Newswires)
09:40AM	Why Pfizer (PFE) is a Top Value Stock for the Long-Term (Zacks)
06:45AM	Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting (Business Wire)
06:00AM	3 Dividend Stocks to Buy on the Dip: April 2024 (InvestorPlace)
Apr-28-24 06:54PM	Dividend Stock Portfolio For Income: Top 5 Stocks (Insider Monkey)
08:00AM	What To Expect in the Markets This Week (Investopedia)
05:50AM	3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street (Motley Fool)
Apr-27-24 09:44AM	30 Most Miserable Countries in the World (Insider Monkey)
07:15AM	3 Dividend Stocks to Buy and Hold for the Next Decade (Motley Fool)
06:00AM	7 Dividend Stocks to Buy Now for Steady Returns in Any Market (InvestorPlace)
Apr-26-24 06:17PM	A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed (Investor's Business Daily)
04:30PM	FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia (Benzinga)
04:07PM	Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure (Investor's Business Daily)
03:57PM	Sector Update: Health Care Stocks Edge Higher Late Afternoon (MT Newswires)
01:24PM	Pfizer Gets FDA Approval for Bleeding Disorder Treatment (MT Newswires)
10:14AM	Pfizer Receives FDA Approval for Bleeding Disorder Treatment (Barrons.com)
09:15AM	Gear Up for Pfizer (PFE) Q1 Earnings: Wall Street Estimates for Key Metrics (Zacks)
09:05AM	Update: Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment (MT Newswires)
07:45AM	Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks (Motley Fool)
07:32AM	Pfizer Receives FDA Approval for Rare Bleeding Disorder Treatment (MT Newswires)
07:00AM	UPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorder (Reuters)
06:46AM	US FDA approves Pfizer's gene therapy for rare bleeding disorder (Reuters)
06:46AM	Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy (Investor's Business Daily)
06:45AM	U.S. FDA Approves Pfizers BEQVEZ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B (Business Wire)
04:50AM	Should You Buy Moderna Before May 12? (Motley Fool)
Apr-25-24 01:51PM	Sector Update: Health Care Stocks Drop in Afternoon Trading (MT Newswires)
01:30PM	CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
01:28PM	Wall Street plunges after US inflation shock (The Telegraph)
12:55PM	Update: GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)
11:42AM	Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma (The Wall Street Journal)
11:31AM	5 Fastest Growing Health Tech Companies in the World (Insider Monkey)
11:27AM	GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines (MT Newswires)
09:54AM	UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
09:39AM	GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology (Reuters)
09:20AM	20 Counties with the Highest Cancer Rates in the US (Insider Monkey)
02:26AM	UPDATE 1-Ad group WPP reports 1.6% drop in first-quarter organic growth (Reuters)
Apr-24-24 04:37PM	Pfizer Declares Second-Quarter 2024 Dividend (Business Wire)
02:45PM	Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break? (Investor's Business Daily)
11:31AM	Alexandria Real Estate Equities, Inc. (NYSE:ARE) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:01AM	Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:41AM	Fiserv, Inc. (NYSE:FI) Q1 2024 Earnings Call Transcript (Insider Monkey)
04:01AM	13 Best Ethical Companies to Invest in 2024 (Insider Monkey)
Apr-23-24 09:15AM	Better Buy: Pfizer vs. Viking Therapeutics (Motley Fool)
07:21AM	Pfizer vs Moderna battle over COVID vaccine patents begins in UK (Reuters)
Apr-22-24 06:08PM	25 Richest Billionaires in Healthcare Industry (Insider Monkey)
05:45PM	Pfizer (PFE) Rises Higher Than Market: Key Facts (Zacks)
11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
08:08AM	European Commission Approves Pfizers EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options (Business Wire)
Apr-21-24 10:43AM	5 Best Dividend Leaders to Buy According to Analysts (Insider Monkey)
10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-20-24 05:50AM	3 Stocks Under $50 You Can Buy Hand Over Fist Right Now (Motley Fool)
Apr-19-24 02:05PM	20 Countries with the Highest Cancer Survival Rates in the World (Insider Monkey)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
Apr-18-24 09:54AM	Bill Miller's Latest 13 Stock Picks (Insider Monkey)
09:15AM	If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
Apr-17-24 06:39AM	Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact (FierceBiotech.com)
06:00AM	Canaan hires Pfizer executive, reels in $100M for biotech investing (BioPharma Dive)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM
Gottlieb Scott	Director	Dec 15 '23	Buy	26.47	3,000	79,401	9,000	Dec 19 09:31 AM
Gottlieb Scott	Director	May 08 '23	Buy	38.58	1,000	38,580	6,000	May 09 04:17 PM
Gottlieb Scott	Director	May 05 '23	Buy	38.42	1,000	38,425	5,000	May 09 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc.

Upgrade your FINVIZ experience